ATMP in Flemingsberg: A networking event for companies and Core Facilities at Campus Flemingsberg

We are pioneers in cell and gene therapies, but it is only through collaboration that we can accelerate in the ATMP field and treat patients. During an intensive and interactive networking event, companies and Core Facilities met to discuss ATMP in the area and identify new collaboration opportunities.

In 2023, the foundation, together with CIMED, the Center for Innovative Medicine, and Karolinska Institutet, initiated an important development program to enhance the opportunities for collaboration between research infrastructures and SMEs, small and medium-sized enterprises in Flemingsberg. As part of the program, we organize networking events with the aim of spreading knowledge about and highlighting the expertise and infrastructure available in the area, and to intensify the collaboration between companies and Core Facilities. The theme for the spring meeting was Advanced Therapy Medicinal Products (ATMP) in Flemingsberg.

”Smartcella’s ambition is to become a leader in targeted ATMP therapies by combining  first-in-class delivery platforms with novel cell and mRNA technology. The unique and historic ATMP ecosystem in Flemingsberg with the research and early development work at Karolinska, as well as other ATMP companies, makes it an ideal location to achieve this ambition.” – Jonathan Clarke, Head of Research and Early Development at SmartCella.

During the event, we brought together two ATMP experts from the area as keynote speakers, Ewa Ellis from Karolinska and Jonathan Clarke from SmartCella. Additionally we were joined by Melissa Nackovski from Merck, who gave a brief introduction to Merck and presented their camper bus which was on campus that day. Finally, the participants were given the opportunity to briefly present their own activities.

Read a report on gender differences in ATMP.

Learn more about ATMP in Flemingsberg.

 

OptiCell Solutions – A Key Player in Cell and Gene Therapy Establishes in Flemingsberg

Flemingsberg continues to be a natural choice for knowledge-intensive and innovative businesses. OptiCell Solutions is a company that recently launched its operations at Novum Labs on the Flemingsberg Campus. Founded in 2024 by specialists from Karolinska University Hospital and entrepreneurs from the Life Science industry, the company specializes in improving the availability of high-quality target cells for cell and gene therapies, a critical component of the growing ATMP (Advanced Therapy Medicinal Products) sector.

Drivhuset Stockholm – Where Future Entrepreneurs Take Their First Steps

Imagine a place where young ideas are free to grow, where passion meets ambition, and where the entrepreneurs of tomorrow take their first steps toward greatness. That’s exactly what Drivhuset Stockholm offers – a springboard for the next generation of entrepreneurs. Located on Campus Flemingsberg, we support students every day as they bring their ideas to life and build the skills needed to create real change. Our mission? To provide them with a safe, inspiring environment where they can test and develop their business ideas for real.

Hitchhiker’s Guide to Startup Success: Mastering the Art of the Perfect Pitch

Earlier this fall, we launched the first event in our seminar series, Hitchhiker’s Guide to Startup Success, which we are organizing together with Miltenyi Biotec. The inaugural session featured an inspiring workshop led by pitch expert and coach Malcolm Larri. The event gathered innovators and entrepreneurs in the Life Sciences sector, with a particular focus on Advanced Therapy Medicinal Products (ATMP)—a rapidly growing field with tremendous potential to revolutionize healthcare.

Go to Top